This inventor holds 1 USPTO granted patent. Top assignee: Novo Nordisk A/s. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: The Innovative Contributions of Thomas Buch Rasmussen
Introduction: Thomas Buch Rasmussen, an accomplished inventor based in Gentofte, Denmark, has made significant strides in the field of medical technology. With a focus on ensuring the precise administration of medicaments, his innovative work reflects a strong commitment to improving healthcare solutions.
Latest Patents: Rasmussen holds a patent for a cutting-edge device designed for the administration of liquid medicament suspensions. The device incorporates an ampoule that features a pierceable seal and a piston to contain the medicament. Notably, it includes a fixation element with metal properties that can attract a magnet. This innovative design allows for a mixing element to be safely positioned within the ampoule while maintaining ease of access for manual operation, thus facilitating effective medication delivery.
Career Highlights: Throughout his career, Thomas Buch Rasmussen has dedicated himself to advancing medical devices at Novo Nordisk A/S, a company renowned for its focus on diabetes care and hormone replacement therapy. His contributions are characterized by a deep understanding of both design and functionality, aimed at enhancing patient outcomes.
Collaborations: Rasmussen's journey in innovation has also been supported by notable colleagues, including Patric Jannasch and Erling Bonne Jo Slashedrgensen. Their collaborative efforts have been pivotal in fostering a creative environment that promotes the development of original ideas and technologies in the medical field.
Conclusion: Thomas Buch Rasmussen's innovative work exemplifies the drive to improve medical solutions through thoughtful design and engineering. His patent for the device aimed at administering liquid medicaments stands as a testament to his commitment to enhancing patient care. As he continues his work in the dynamic and impactful environment at Novo Nordisk A/S, it is evident that Rasmussen will remain a key figure in the realm of medical innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile